Our results indicate that SCNN1A was upregulated in metformin-treated samples relative to diet-controlled patient samples and non-diabetic samples from patients who were deceased at five years and corresponded to expression levels seen in non-diabetic samples from patients who were alive five years following their CRC diagnosis. The gene discussed is SCNN1A; the disease is colorectal carcinoma.